LNCaP clone FGC Cell Complete Medium procell CM-0143
$98.00
In stock
SKU
CM-0143
volume:：125mL×4
| Form:：Liquid | Bacteria Detection:：Negative |
| Fungi Detection:：Negative | Mycoplasma Detection:：Negative |
| Endotoxin Content:： | pH:：7.4-7.8 |
| Components:：RPMI-1640 [PM150110]+10% Nutrient+1% Supplement | Green Features:：Sustainable packaging |
| Valid Period:：6 months | Storage Condition:：This product can be stored at 2-8℃ for 6 months with shading light. |
| Matters Need Attention:：1. This product is for research use only. 2. This product is sterilized by 0.1 μm filtration. 3. It is necessary to pay attention to the aseptic operation and avoid the contamination during the culture. 4. It is not suitable for long time storage at room temperature. 5. This product is a ready-to-use medium. If there is no special need, don't add serum, penicillin and streptomycin. It can be used directly. | System Certification:：GMP Production and Quality System The company complies with cGMP requirements, holds the NMPA medical device registration certificate, and is certified under ISO 13485 and ISO 9001 standards. Among its products, the company's LNCaP clone FGC Cell Complete Medium complies with ISO 9001. |
| biogegep7 | biogegep17 |
| biogegep8 | biogegep18 |
| biogegep9 | biogegep19 |
| biogegep10 | biogegep20 |
Title: Natural Flavonoids Genistein and Baicalein as Well-Tolerated Radiosensitizers to Enhance the Efficacy of 177Lu-PSMA617 in Prostate Cancer: In?Vitro and In?Vivo Studies
Journal: Research (2026)
IF: 12.9
DOI: 10.34133/research.1314
Article URL: https://spj.science.org/doi/abs/10.34133/research.1314
Product Cited: LNCaP clone FGC Cells Line, LNCaP clone FGC Cell Complete Medium
Title: An E3 Aptamer-Modified T Cell-Derived Exosomal Nanoplatform for Codelivery of Astragaloside IV and PESV: Enhancing Prostate Cancer Therapy Through Immune Modulation with Implications for Clinical Translation
Journal: International Journal of Nanomedicine (2026)
IF: 8.7
DOI: 10.2147/IJN.S614400
Article URL: https://www.dovepress.com/an-e3-aptamer-modified-t-cell-derived-exosomal-nanoplatform-for-codeli-peer-reviewed-fulltext-article-IJN
Product Cited: LNCaP clone FGC Cell Complete Medium
Title: Integrated computational and experimental analysis explores FOLH1 expression patterns across cancers and nominates melatonin as a potential modulator in prostate cancer models
Journal: PLoS Computational Biology (2026)
IF: 3.7
DOI: 10.1371/journal.pcbi.1014315
Article URL: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1014315
Product Cited: Poly-L-Lysine Solution, 10 ×, LNCaP clone FGC Cell Complete Medium
Title: CASER: A semi-supervised model with multi-omics data integration prioritizes cancer-associated epigenetic regulator genes
Journal: PLoS Computational Biology (2026)
IF: 3.6
DOI: 10.1371/journal.pcbi.1014253
Article URL: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1014253
Product Cited: SK-MEL-2 Cell Complete Medium, LNCaP clone FGC Cells Line, Caki-1 Cells Line, Caki-1 Cell Complete Medium, MDA-MB-231 (L15) Cell Complete Medium, LNCaP clone FGC Cell Complete Medium, SK-MEL-2 Cells Line, MDA-MB-231 Cells Line
Title: Hyperoside Inhibits RNF8-mediated Nuclear Translocation of β-catenin to Repress PD-L1 Expression and Prostate Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry (2024)
IF: 2.6
DOI: 10.2174/0118715206289246240110044931
Article URL: https://www.ingentaconnect.com/content/ben/acamc/2024/00000024/00000006/art00009
Product Cited: LNCaP clone FGC Cell Complete Medium
Reviews
Write Your Own Review